Yves Rosconi, president & CEO of Theratechnologies, will retire Dec. 31. Release
Rigel Pharmaceuticals has named Raul Rodriguez as president and promoted Ryan Maynard and Dolly Vance to executive VPs. Release
Amylin Pharmaceuticals appoints Christian Weyer, senior VP, R&D and named Orville Kolterman as senior VP, chief medical officer.
Ikaria has tapped Douglas Greene as executive VP of R&D. Release
PharmaGap has announced the appointment of the appointment of Kenneth Sokoll, to the company's clinical development group. Release
Alnylam Pharmaceuticals has named Laurence Reid as senior VP, chief business officer, and Kenneth Koblan, as VP, distinguished Alnylam Fellow. Release
Xytos has appointed John Trotter II as the company's new chief medical officer. Release
Genstruct has appointed David de Graaf as its chief scientific officer. Release
Alexion Pharmaceuticals has announced the appointment of Ann Veneman to the company's board of directors. Release